A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Clinical trial NCT05545319 · WITHDRAWN

Trial details

NCT number: NCT05545319
Sponsor: Pfizer
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Coronavirus Disease 2019 (COVID-19)Immunocompromised Hospitalization Child, Hospitalized

Start date: 2022-12-13
Primary completion: 2023-09-21
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.